Indivior Pharmaceuticals (INDV) Other Working Capital Changes (2024 - 2026)

Indivior Pharmaceuticals' Other Working Capital Changes history runs 3 years deep, the most recent figure standing at $18.0 million for Q1 2026.

• In Q1 2026, Other Working Capital Changes changed 0.0% year-over-year to $18.0 million; the TTM figure through Mar 2026 stood at -$49.0 million (down 232.43% YoY), while the FY2025 annual figure was -$49.0 million, up 87.0% from the prior year.
• Other Working Capital Changes was $18.0 million for Q1 2026 at Indivior Pharmaceuticals, up from -$11.0 million in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $18.0 million in Q1 2025 to a low of -$396.0 million in Q1 2024.
• Historically, Other Working Capital Changes has averaged -$45.3 million across 3 years, with a median of $3.0 million in 2024.
• Biggest YoY gain for Other Working Capital Changes was 104.55% in 2025; the steepest drop was 1733.33% in 2025.
• A 3-year view of Other Working Capital Changes shows it stood at $12.0 million in 2024, then plunged by 191.67% to -$11.0 million in 2025, then jumped by 263.64% to $18.0 million in 2026.
• The last three Other Working Capital Changes figures came in at $18.0 million (Q1 2026), -$11.0 million (Q4 2025), and -$7.0 million (Q3 2025), per Business Quant data.